Institute for Cancer Research
Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has at present seven research departments and more than 230 employees. More than half of the staff are externally funded. Many of the researchers have national and international commissions and ongoing collaborations.
The research at the Institute was collectively described as "very good, on the border of outstanding" by an international panel evaluating Norwegian biomedical research on behalf of The Norwegian Research Council.
Scientific director
Scientific production - Institute for Cancer Research
| PubMed articles | Doctoral theses | |
| 2010 | so far | |
| 2009 | 191 | 22 |
| 2008 | 184 | 11 |
| 2007 | 161 | 16 |
| 2006 | 176 | 12 |
| 2005 | 154 | 12 |
Print this page [48637 visits]Latest news
Group at Institute for Cancer Research identifies new functional mechanism for a tumour suppressor
PhD student Antonia Sagona and her co-workers in Harald Stenmark´s group at the Centre for Cancer Biomedicine, Institute for Cancer Research, have uncovered a new functional mechanism for a known tumour suppressor, the class III phosphatidylinositol 3-kinase (PI3K-III), a protein complex that mediates formation of the membrane lipid, phosphatidylinositol 3-phosphate (PtdIns3P). The findings are published as a main article in the April 2010 issue (advance online publication 7 March 2010) of Nature Cell Biology (impact factor 17.774) .
Molecular Genetics group publishes in Journal of Clinical Oncology
The "Molecular Genetics group" at the Department of Cancer Prevention and the Centre for Cancer Biomedicine, headed by Ragnhild A. Lothe, has recently published a translational research paper in the highly rated Journal of Clinical Oncology (journal impact factor 17.2). The article - entitled "Genomic Changes in Chromosomes 10, 16, and X in Malignant Peripheral Nerve Sheath Tumors Identify a High-Risk Patient Group" is published in the "Translational oncology" section.
The first three authors are PhD candidate Helge R. Brekke (1st author), Dr. Franclim Ribeiro and Dr. Matthias Kolberg.
Mar 8, 2010
21st Meeting of the European Association for Cancer Research, 26 - 29 June 2010
Feb 25, 2010
Latest publications
Inst. for Cancer Research
Elevated Osteopontin Levels in Metastatic Melanoma Correlate with Epigenetic Silencing of Breast Cancer Metastasis Suppressor 1
Oncology, 78 (1), 75-86 (in press)
PubMed 20215788
Bone Marrow Micrometastases Studied by an Immunomagnetic Isolation Procedure in Extremity Localized Non-metastatic Osteosarcoma Patients
Cancer Treat Res, 152, 509-15
PubMed 20213412
Unstable DNA Repair Genes Shaped by Their Own Sequence Modifying Phenotypes
J Mol Evol (in press)
PubMed 20213140
Selected publications
Journal Impact Factor > 5, first or last author from the Institute for Cancer Research
PtdIns(3)P controls cytokinesis through KIF13A-mediated recruitment of FYVE-CENT to the midbody
Nat Cell Biol (in press)
PubMed 20208530
(Impact 17.8)
p62, an autophagy hero or culprit?
Nat Cell Biol, 12 (3), 207-9
PubMed 20190829
(Impact 17.8)
Genomic Changes in Chromosomes 10, 16, and X in Malignant Peripheral Nerve Sheath Tumors Identify a High-Risk Patient Group
J Clin Oncol (in press)
PubMed 20159821
(Impact 17.2)
